Out of 705, 476 were nonbenign and observed in patients with PFIC2 or other cholestatic diseases including, benign recurrent intrahepatic cholestasis type 2, ICP, and/or an unspecified/nonsyndromic form of cholestasis (supplemental Table S1). Here, ABCB11 is linked to benign recurrent intrahepatic cholestasis.